77 results
6-K
EX-99.1
LEGN
Legend Biotech Corp
3 Jun 24
Current report (foreign)
4:05pm
receptor T-cell, gamma-delta T cell (gd T) and natural killer (NK) cell-based immunotherapy. From our three R&D sites around the world, we apply
6-K
EX-99.1
LEGN
Legend Biotech Corp
23 May 24
Legend Biotech to Highlight Leadership in CAR-T Cell Therapy for Patients with Multiple Myeloma at ASCO and EHA
5:00pm
autologous and allogeneic chimeric antigen receptor T-cell, gamma-delta T cell (gd T) and natural killer (NK) cell-based immunotherapy. From our three R&D sites
6-K
EX-99.1
LEGN
Legend Biotech Corp
13 May 24
Legend Biotech Reports First Quarter 2024 Results and Recent Highlights
7:01am
-based immunotherapy. From our three R&D sites around the world, we apply these innovative technologies to pursue the discovery of cutting-edge
6-K
EX-99.1
LEGN
Legend Biotech Corp
22 Apr 24
Current report (foreign)
1:06pm
) cell-based immunotherapy. From our three R&D sites around the world, we apply these innovative technologies to pursue the discovery of cutting-edge
6-K
EX-99.1
LEGN
Legend Biotech Corp
8 Apr 24
Current report (foreign)
7:03am
cell (gd T) and natural killer (NK) cell-based immunotherapy. From our three R&D sites around the world, we apply these innovative technologies
6-K
EX-99.1
koi33fzin hd5eifn
15 Mar 24
FDA ODAC votes 11 to 0 supporting favorable risk-benefit assessment of CARVYKTI based on results from the Phase 3 CARITUDE-4 study
3:18pm
6-K
EX-99.1
j8skw
11 Mar 24
Legend Biotech Reports Fourth Quarter and Full Year 2023 Results and Recent Highlights
7:52am
6-K
EX-99.1
z33sx0
23 Feb 24
Current report (foreign)
7:16am
6-K
EX-99.1
ny0zb 0a3s
9 Jan 24
Legend Biotech Corporation 6-K
4:01pm
6-K
EX-99.1
9c30gjam m9pf
11 Dec 23
Legend Biotech Corporation 6-K
7:32pm
6-K
EX-99.1
gj90k vjy
20 Nov 23
Legend Biotech Reports Third Quarter 2023 Results and Recent Highlights
6:02am
6-K
EX-99.1
iuyzhcqswt1ws
13 Nov 23
Legend Biotech Corp. 6-K
8:30am
6-K
EX-99.1
5mntrpxjq
15 Aug 23
Legend Biotech Reports Second Quarter 2023 Results and Recent Highlights
6:10am
6-K
EX-99.1
xrbwu 5xtb
6 Jun 23
Legend Biotech Corporation 6-K
4:44pm
6-K
EX-99.1
bfwr3uf
5 Jun 23
Legend Biotech 6-K
11:17am
6-K
EX-99.1
k0xw2w1k
25 May 23
Legend Biotech Corporation 6-K
8:30am
6-K
EX-99.1
e2p6jl0bo8hy75yffza
18 May 23
Legend Biotech Corporation 6-K
8:30am
6-K
EX-99.1
2dw8bl9 ied3bzszpt
16 May 23
Legend Biotech Corporation 6-K
8:39am
6-K
EX-99.1
qkxhqb g9et
8 May 23
Announces Pricing of Registered Direct Offering of US$350 million of American Depositary Shares
8:46am
6-K
EX-99.1
dhxh0bnlkctmof
3 Apr 23
Legend Biotech 6-K
4:01pm